ZENARA FDA Approval ANDA 213891

ANDA 213891

ZENARA

FDA Drug Application

Application #213891

Application Sponsors

ANDA 213891ZENARA

Marketing Status

Prescription001

Application Products

001TABLET;ORALEQ 2.5MG BASE0FROVATRIPTAN SUCCINATEFROVATRIPTAN SUCCINATE

FDA Submissions

UNKNOWN; ORIG1AP2022-04-06STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAB

CDER Filings

ZENARA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 213891
            [companyName] => ZENARA
            [docInserts] => ["",""]
            [products] => [{"drugName":"FROVATRIPTAN SUCCINATE","activeIngredients":"FROVATRIPTAN SUCCINATE","strength":"EQ 2.5MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"04\/06\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2022-04-06
        )

)

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.